This could start to bring down the cost of brand-name competitors—here's who may get to use it, and one major difference from ...
The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a ...
In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...
Novo Nordisk has filed another Citizen's Petition with the FDA seeking to block compounding pharmacies in the US from making ...
Semaglutide, the active ingredient in Ozempic and Wegovy, was also included on the list. The FDA is prioritizing the review ...
Liraglutide, the generic for Victoza, is similar to semaglutide, the active ingredient in the popular weight-loss drug Ozempic. The FDA supports the development of generic drugs, such as GLP-1s ...
Hopefully, the approval will help prevent shortages triggered by demand for injectable weight loss drugs such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) There is still ...